A world-renowned diabetes expert and molecular biologist, Arthur (Art) Riggs pioneered the lifesaving recombinant protein and antibody drugs on which the biotech industry was built.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Huberman, J. A. & Riggs, A. D. J. Mol. Biol. 32, 327–341 (1968).
Smit, A. F. Nucleic Acids Res. 21, 1863–1872 (1993).
Riggs, A. D. & Bourgeois, S. J. Mol. Biol. 34, 361–364 (1968).
Riggs, A. D., Bourgeois, S., Newby, R. F. & Cohn, M. J. Mol. Biol. 34, 365–368 (1968).
Riggs, A. D. Cytogenet. Cell Genet. 14, 9–25 (1975).
Holliday, R. & Pugh, J. E. Science 187, 226–232 (1975).
Heyneker, H. L. et al. Nature 263, 748–752 (1976).
Itakura, K. et al. Science 198, 1056–1063 (1977).
Mossman, K. D. Proc. Natl Acad. Sci. USA 107, 5269–5271 (2010).
Goeddel, D. V. et al. Proc. Natl Acad. Sci. USA 76, 106–110 (1979).
Riggs, A. D. Endocr. Rev. 42, 374–380 (2021).
Cabilly, S. et al. Proc. Natl Acad. Sci. USA 81, 3273–3277 (1984).
Riggs, A. D. & Pfeifer, G. P. Trends Genet. 8, 169–174 (1992).
Singer-Sam, J. et al. Mol. Cell. Biol. 10, 4987–4989 (1990).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pfeifer, G.P., Singer-Sam, J. & Itakura, K. Arthur D. Riggs 1939–2022. Nat Biotechnol 40, 1317–1318 (2022). https://doi.org/10.1038/s41587-022-01453-5
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41587-022-01453-5
